View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B3 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Transaction in Own Shares
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Factbox-Big banks expect a quarter-point cut for ECB's first meeting of 2025
-
AIG Announces Results and Upsizing of Its Tender Offers for Certain Outstanding Notes
-
Candel Therapeutics (CADL) Prices Public Offering
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
FedEx (FDX) PT Lowered to $330 at Citi
-
Citi Reiterates Buy Rating on Constellation Brands (STZ)
-
Citi Opens 90-Day Upside Catalyst Watch on Duke Energy (DUK)
-
Citi Reiterates Buy Rating on Nike (NKE)
-
Candel Therapeutics Announces Pricing of Public Offering
-
DigiCo REIT in tepid debut after marking Australia's biggest IPO in six years
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Candel Therapeutics (CADL) Announces $80 Million Proposed Public Offering
-
Candel Therapeutics Announces $80 Million Proposed Public Offering
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC

